Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2003
12/03/2003EP1366146A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366078A2 Ige receptor antagonists
12/03/2003EP1366076A2 Compounds and methods for modulating desmosomal cadherin-mediated functions
12/03/2003EP1366075A2 New interferon beta-like molecules
12/03/2003EP1366074A2 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity
12/03/2003EP1366071A2 Dna-sequences, which code for an apoptosis signal transduction protein
12/03/2003EP1366068A1 Poynucleotide and polypeptide from group b streptococcus and use thereof for the preparation of a vaccine
12/03/2003EP1366066A2 Cyclohexapeptide having antimicrobial activity
12/03/2003EP1366065A1 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs
12/03/2003EP1366064A1 Tumour targeting prodrugs activated by metallo matrixproteinases
12/03/2003EP1366063A2 Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancr
12/03/2003EP1366062A2 Efficient recovery of correctly refolded proteins
12/03/2003EP1366060A2 Methods of purification and recovery of interferon-beta
12/03/2003EP1366059A2 Methods and compositions for modulating gluconeogenesis using pgc-1
12/03/2003EP1366022A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
12/03/2003EP1366017A2 Non-natural basic amino acids, their preparation and use
12/03/2003EP1365806A2 Use of no acttivators for treatment and prevention of gastrointestinal disorders
12/03/2003EP1365804A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
12/03/2003EP1365801A1 Methods and materials relating to fibulin-like polypeptides and polynucleotides
12/03/2003EP1365800A2 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/03/2003EP1365798A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
12/03/2003EP1365797A2 Methods and agents modulating upa/upar activity
12/03/2003EP1365796A2 Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma
12/03/2003EP1365795A1 Use of the g-csf as additional treatment in the reconstruction of connective tissue
12/03/2003EP1365794A2 Prevention and treatment of sexual arousal disorders
12/03/2003EP1365793A2 Treatment of inflammatory bowel disease using growth factors
12/03/2003EP1365792A2 Composition and process for bone growth and repair
12/03/2003EP1365791A2 Cyclosporins for the treatment of respiratory diseases
12/03/2003EP1365790A2 Diagnostic indicator of thymic function
12/03/2003EP1365789A1 Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof
12/03/2003EP1365788A2 Thrombomodulin analogs for use in recovery of signal cord injury
12/03/2003EP1365787A2 New uses for amino acid anticonvulsants for treatment of pain
12/03/2003EP1365786A2 Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel
12/03/2003EP1365785A2 Use of ciliary neurotrophic factor
12/03/2003EP1365781A1 Acrochordon alleviation
12/03/2003EP1365774A2 Use of zwitterionic polysaccharides for the specific modulation of immune processes
12/03/2003EP1365769A1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
12/03/2003EP1365766A2 Pharmaceutical composition for treatment of phimosis using topical corticosteroid
12/03/2003EP1365765A2 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
12/03/2003EP1365759A2 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
12/03/2003EP1365753A2 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
12/03/2003EP1365747A1 Oral peptide pharmaceutical dosage form and method of production
12/03/2003EP1365746A1 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer
12/03/2003EP1246634B1 Neurotoxins for treating pancreatic disorders
12/03/2003EP1187847B1 Streptogramin derivatives, preparation and compositions containing them
12/03/2003EP1165184B1 Estrogen receptor-beta antagonism and bone diseases
12/03/2003EP1064306B1 Nephrin gene and protein
12/03/2003EP1045709B1 Method and device for in-situ formulation of a medicinal solution for parenteral application
12/03/2003EP1037643B1 Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
12/03/2003EP0975369B1 Polyethylene glycol-interferon alpha conjugates for therapy of infections
12/03/2003EP0952982B1 Novel hepatitis b inhibitors
12/03/2003EP0901405B1 Fibrinogen apparatus, method and container
12/03/2003EP0874624B1 Hyaluronic acid receptors binding agents and their use for treating tumors or restenosis
12/03/2003EP0859830B1 Growth of adult pancreatic islet cells with laminin 5
12/03/2003EP0832196B1 Immortalization and disimmortalization of cells
12/03/2003EP0832095B1 A method of cross-linking amino acid-containing polymers using photoactivatable chemical cross-linkers
12/03/2003EP0821004B1 Peptides and remedy for bone diseases containing the same as active ingredient
12/03/2003EP0772466B1 Compositions and methods for a bioartificial extracellular matrix
12/03/2003EP0767666B1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
12/03/2003EP0758233B1 Pde iv inhibitors for treating multiple sclerosis
12/03/2003EP0724644B1 Dna encoding 1,3-beta-d glucan synthase subunits
12/03/2003EP0687295B1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
12/03/2003CN1460181A Nucleic acid sequences and protein involved in cellular senescence
12/03/2003CN1460100A Compounds and compositions for delivering active agents
12/03/2003CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides
12/03/2003CN1460024A Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1460018A Implantable gel compositions and method of mfg.
12/03/2003CN1459505A Chinese Han nationality people stroma metallopankrin-9 gene reconstitution, expression, purification and its medical application
12/03/2003CN1459459A Preparation and assaying of peptide dextran possessing detectable oral absorption immune regulation of rainbow conk
12/03/2003CN1129666C Human tissue inhibitor of metalloproteinase -4
12/03/2003CN1129608C Method and apparatus for preparing acellular red blood cell substitute
12/03/2003CN1129606C Heptapeptide oxytocin analogues
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129603C Heterocycles, its preparation, application and medicine contanining same
12/03/2003CN1129452C Buccal tablet of epidermal growth factor
12/03/2003CN1129451C Process for preparing injection liquid of brain protein hydrolyzate
12/03/2003CN1129436C Oral care composition comprising bacillus pullulanase and dextranase
12/02/2003US6657104 Cell-based, and whole-animal-based assays for detecting substances having therapeutic activity toward cardiac hypertrophy.
12/02/2003US6657103 Human antibodies derived from immunized xenomice
12/02/2003US6657056 Compounds for immunotherapy of prostate cancer and methods for their use
12/02/2003US6657055 Detection of modulators of immune response; obtain cell sample, incubate with fusion proteins, monitor cells for immune response
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656965 HIV protease inhibitors based on amino acid derivatives
12/02/2003US6656922 Oral delivery of macromolecules
12/02/2003US6656918 Contacting the ductal epithelium of the exocrine gland with epithelium destroying agents such as ethanol and vaccinia virus
12/02/2003US6656911 Serine protease inhibitors
12/02/2003US6656910 Substituted oxadiazole, thiadiazoles and triazole peptoids for treating adult respiratory distress syndrome, septic shock, and myocardial ischemia-reperfusion injury
12/02/2003US6656907 Method of treating gastric ulcer by administration of epidermal growth factor
12/02/2003US6656906 Hybrid polypeptides with enhanced pharmacokinetic properties
12/02/2003US6656905 Cyclic tetrapeptide compound and use thereof
12/02/2003US6656904 Inhibitors of proteasomal activity for stimulating bone and hair growth
12/02/2003US6656746 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders
12/02/2003US6656743 Human choline acetyltransferase
12/02/2003US6656732 Antisense inhibition of src-c expression
12/02/2003US6656731 Nucleic acid catalysts with endonuclease activity
12/02/2003US6656730 Attached to an arylpropionic acid that interacts with human serum albumin; acid is ibuprofen, suprofen, ketoprofen, (S)-(+)- pranoprofen, or carprofen.
12/02/2003US6656728 Fusions of the extracellular domain of a fibroblast growth factor receptor with a heterologous oligomerization domain, such as that contained in an immunoglobulin, to provide potent FGFR antagonists.
12/02/2003US6656716 Polypeptide fragments of human PAK5 protein kinase
1 ... 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 ... 3163